Objectives:
▶To provide an opportunity of both international exchange of academic interests in pharmacokinetics/pharmacodynamics (PK/PD) areas and dissemination of up-to-date methodologies to pharmaceutical people
▶To discuss the latest developments in PK/PD modeling & simulation and its applications in drug development, regulatory decision and clinical practice
Topics:
▶Novel concepts in clinical pharmacology (PK/PD)
▶Biomarkers, Surrogate endpoints
▶Detection and prediction of drug efficacy and safety
▶Subject compliance
▶Disease model
▶Optimization of dosage regimen design
▶Role of regulation agency
▶Modeling and simulation in drug development, regulatory decision and clinical applications
|